MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2016 International Congress

    The effect of improved nutritional status on psychiatric features and quality of life in Parkinson’s disease patients

    N. Ongun, C. Erdogan, E. Degirmenci, L.S. Bir (Denizli, Turkey)

    Objective: To determine the effect of nutritional status in 6 weeks time on depression, anxiety and quality of life in Parkinson's disease (PD) patients. Background:…
  • 2016 International Congress

    Cognitive impairment in Parkinson’s disease

    B. Kurbanov (Tashkent, Uzbekistan)

    Objective: To study features of cognitive symptoms in PD, depending on the severity of the disease. Background: Parkinson's disease (PD) is shown a wide range…
  • 2016 International Congress

    Impact of pre- and postdiagnosis physical activity on the progression of Parkinson’s disease

    I.F. Shih, K.C. Paul, Y. Bordelon, J.M. Bronstein, B. Ritz (Los Angeles, CA, USA)

    Objective: To assess whether and how pre- and postdiagnosis physical activities affect motor function, cognition, and depression among Parkinson's disease (PD) patients. Background: Physical activities…
  • 2016 International Congress

    Cognitive function and self-reported depressive symptoms in a population-based cohort to study non-motor-symptoms of Parkinson’s disease

    E.J. Vollstedt, K. Hückelheim, S. Tunc, J. Hampf, C. Kritzinger, M. Kasten, C. Klein (Luebeck, Germany)

    Objective: To describe the relation of depressive symptoms with cognitive performance in our cohort at baseline and two-year follow-up. Background: Cognitive function (CF) is frequent…
  • 2016 International Congress

    Neuroprotective and antidepressant-like effects of the endogenous amines from tetrahydroisoquinoline group TIQ and 1MeTIQ in the animal model of depressive disorder: Behavioral and neurochemical studies in the rat

    L.R. Antkiewicz-Michaluk (Krakow, Poland)

    Objective: For the purpose of estimation neuroprotective and antidepressant-like effects of the endogenous amines 1,2,3,4-tetrahydroisoquinoline (TIQ) and its close methyl derivative, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ) in the…
  • 2016 International Congress

    Relationship between the MDS-UPDRS and quality of life in Parkinson’s disease: A large international multicenter study of 3206 patients (the QUALPD study)

    M. Škorvánek, P. Martinez-Martin, N. Kovacs, I. Zezula, M. Rodriguez-Violante, J.C. Corvol, P. Taba, K. Seppi, O. Levin, A.E. Schrag, T. Foltynie, M. Alvarez-Sanchez, T. Arakaki, Z. Aschermann, I. Aviles-Olmos, E. Benchetrit, C. Benoit, A. Bergareche-Yarza, A. Cervantes-Arriaga, A. Chade, F. Cormier, V. Datieva, D.A. Gallagher, N. Garretto, Z. Gdovinova, O. Gerschanik, M. Grofik, V. Han, J. Huang, L. Kadastik-Eerme, M.M. Kurtis, G. Mangone, J.C. Martinez-Castrillo, A. Mendoza-Rodriguez, M. Minar, H.P. Moore, M. Muldmaa, C. Mueller, B. Pinter, W. Poewe, K. Rallmann, E. Reiter, C. Rodriguez-Blazquez, C. Singer, B.C. Tilley, P. Valkovic, C.G. Goetz, G.T. Stebbins (Kosice, Slovakia (Slovak Republic))

    Objective: To evaluate the relationship between the International Parkinson and Movement Disorder Society – Unified Parkinson's disease Rating Scale (MDS-UPDRS) and Quality of Life (QoL)…
  • 2016 International Congress

    The role of depression in suicidal ideation in a sample of patients with Parkinson’s disease

    M.M. Dumitru (Iasi, Romania)

    Objective: The objective of this study was to assess the frequency of suicidal ideation and suicide attempts in a sample of consecutive patients with Parkinson's…
  • 2016 International Congress

    Preclinical evaluation of sub-anesthetic ketamine infusion to reduce L-DOPA-induced dyskinesias: Is it a ‘chemical’ DBS?

    T. Falk, M.J. Bartlett, T. Ye, L.B. Lazarus, M.L. Heien, S.L. Cowen, S.J. Sherman (Tucson, AZ, USA)

    Objective: To evaluate mechanism of long-term activity of sub-anesthetic ketamine infusion to reduce L-DOPA-induced dyskinesias (LID). Background: Ketamine is an anesthetic that, when administered as…
  • 2016 International Congress

    Greater incidence of depressive symptoms in atypical parkinsonism: Importance of early screening

    L. Almeida, B. Ahmed, R. Walz, S. De Jesus, A. Patterson, D. Martinez-Ramirez, D. Vaillancourt, D. Bowers, H. Ward, M.S. Okun, M. Armstrong, N. McFarland (Gainesville, FL, USA)

    Objective: To evaluate the incidence of depressive symptoms in Parkinsonian patients in a large cohort followed at a tertiary movement disorders center. Background: Despite relative…
  • 2016 International Congress

    Life satisfaction in Parkinson’s disease – associated factors

    K. Rosqvist, P. Hagell, P. Odin, S. Iwarsson, H. Ekström, M.H. Nilsson (Lund, Sweden)

    Objective: To identify factors associated with life satisfaction (LS) in people with Parkinson's disease (PD), including a specific focus on those with late stage PD.…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley